JPMorgan Chase & Co. Boosts Holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

JPMorgan Chase & Co. boosted its stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 241.7% during the 3rd quarter, Holdings Channel reports. The firm owned 4,046 shares of the company’s stock after acquiring an additional 2,862 shares during the quarter. JPMorgan Chase & Co.’s holdings in Invesco Pharmaceuticals ETF were worth $352,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in the company. Envestnet Asset Management Inc. grew its position in Invesco Pharmaceuticals ETF by 87.7% during the second quarter. Envestnet Asset Management Inc. now owns 23,878 shares of the company’s stock valued at $1,963,000 after buying an additional 11,156 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of Invesco Pharmaceuticals ETF by 49.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 6,826 shares of the company’s stock valued at $561,000 after purchasing an additional 2,266 shares in the last quarter. HBW Advisory Services LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF in the 3rd quarter worth $509,000. Secure Asset Management LLC purchased a new stake in Invesco Pharmaceuticals ETF in the third quarter valued at $229,000. Finally, Joseph Group Capital Management raised its position in Invesco Pharmaceuticals ETF by 16.0% in the third quarter. Joseph Group Capital Management now owns 15,080 shares of the company’s stock valued at $1,312,000 after purchasing an additional 2,079 shares during the period.

Invesco Pharmaceuticals ETF Stock Up 0.1 %

Invesco Pharmaceuticals ETF stock opened at $86.11 on Thursday. Invesco Pharmaceuticals ETF has a 52-week low of $75.33 and a 52-week high of $89.87. The firm has a market cap of $291.91 million, a PE ratio of 21.48 and a beta of 0.61. The company’s 50 day moving average is $84.34 and its two-hundred day moving average is $85.73.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.